NASAL Allergy 24 Hour

Manufacturer: Geiss, Destin & Dunn Inc. | Teva Pharmaceuticals USA Inc
Effective date: 2015-06-19
Label type: HUMAN OTC DRUG LABEL
Version: 2
Source: full-release
Hydrated at: 2026-05-31 22:42:48

Label at a glance#

ProductNASAL Allergy 24 Hour

Active ingredientTRIAMCINOLONE ACETONIDE

Label structure10 sections

Indications and uses

temporarily relieves these symptoms of hay fever or other upper respiratory allergies: ■ nasal congestion ■ runny nose ■ sneezing ■ itchy nose

Dosage and administration

Read insert (inside package) on how to: ■ get a new bottle ready (primed) before first use ■ prime bottle again if not used for more than 2 weeks ■ use the spray ■ clean the spray nozzle ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER adults and children 12 years of age and older ■ once daily, spray 2 times into each nostril while sniffing gently ■ once your allergy symptoms improve, reduce to 1 spray in each nostri...

Contacts and useful links#

PhonePoison Help1-800-222-1222

PhoneLabel contact1-888-838-2872

Label contents#

Full prescribing information#

Active ingredient (in each spray)

OTC - ACTIVE INGREDIENT SECTION

Triamcinolone acetonide (glucocorticoid) 55 mcg

Purpose

OTC - PURPOSE SECTION

Nasal allergy symptom reliever

Keep Out of Reach of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Uses

INDICATIONS & USAGE SECTION

temporarily relieves these symptoms of hay fever or other upper respiratory allergies:

nasal congestion
runny nose
sneezing
itchy nose

Warnings

WARNINGS SECTION

Do not use

in children under 2 years of age
if you have ever had an allergic reaction to any of the ingredients

Ask a doctor before use if you

have had recent nose ulcers or nose surgery
have had a nose injury that has not healed
are using a steroid medicine for asthma, allergies or skin rash
have an eye infection
have or had glaucoma or cataracts

When using this product

the growth rate of some children may be slower
some symptoms may get better on the first day of treatment. It may take up to one week of daily use to feel the most symptom relief.
do not share this bottle with anyone else as this may spread germs
remember to tell your doctor about all the medicines you take, including this one

Stop use and ask a doctor if

you have, or come into contact with someone who has, chickenpox, measles or tuberculosis
you have or develop symptoms of an infection such as a persistent fever
you have any change in vision
you have severe or frequent nosebleeds

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Directions

DOSAGE & ADMINISTRATION SECTION

Read insert (inside package) on how to:

get a new bottle ready (primed) before first use
prime bottle again if not used for more than 2 weeks
use the spray
clean the spray nozzle

ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER
adults and children 12 years of age and older	once daily, spray 2 times into each nostril while sniffing gently once your allergy symptoms improve, reduce to 1 spray in each nostril per day
CHILDREN 2 TO UNDER 12 YEARS OF AGE
the growth rate of some children may be slower while using this product. Talk to your child’s doctor if your child needs to use the spray for longer than two months a year.
children 6 to under 12 years of age	an adult should supervise use once daily, spray 1 time into each nostril while sniffing gently if allergy symptoms do not improve, increase to 2 sprays in each nostril per day. Once allergy symptoms improve, reduce to 1 spray in each nostril per day.
children 2 to under 6 years of age	an adult should supervise use once daily, spray 1 time into each nostril while sniffing gently
children under 2 years of age	do not use

do not use more than directed
if you forget a dose, do not double the next dose
do not spray into eyes or mouth
if allergy symptoms do not improve after one week, stop using and talk to a doctor
do not use for the common cold
shake well before each use

Other information

SPL UNCLASSIFIED SECTION

do not use if sealed package is torn or opened
keep package and insert. They contain important information.
store between 20°-25°C (68°-77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

benzalkonium chloride, carboxymethylcellulose sodium, dextrose anhydrous, edetate disodium dihydrate, hydrochloric acid or sodium hydroxide (for pH adjustment), microcrystalline cellulose, polysorbate 80, purified water

Questions or comments?

OTC - QUESTIONS SECTION

1-888-838-2872

Package/Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NASAL Allergy 24 HOUR Carton Text

SPL UNCLASSIFIED SECTION

Original Prescription Strength

Compare to Nasacort® Allergy 24 HR active ingredient

NDC 50804-085-17

Multi-Symptom · Nasal Allergy Spray

NASAL

Allergy 24 HOUR

Triamcinolone Acetonide (Glucocorticoid)

55 mcg Per Spray/Nasal Allergy Symptom Reliever

24 HR RELIEF OF:

Nasal Congestion
Sneezing
Runny Nose
Itchy Nose

120 Sprays

0.57 FL OZ (16.9 mL)

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
1797913	triamcinolone acetonide 55 MCG/ACTUAT Metered Dose Nasal Spray	PSN	2
1797913	triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray	SCD	2
1797913	triamcinolone acetonide 55 MCG/ACTUAT Metered Dose Nasal Spray	SY	2

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
TRIAMCINOLONE ACETONIDE Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d4d7da1a-7fd4-628e-cdae-89e749b1c534	Product name	7	20260127
75f7e47b-8736-a182-fc44-22aca8d79689	Product name	2	20251211
62986c8d-91f1-b1ba-b5a3-8b54b75bb8c2	Product name	6	20250516
e42f429b-c4e5-0402-e1c5-730154df4060	Product name	4	20240205
cb89b86a-369e-4204-8910-ae797c503af3	Product name	1	20230706
38d4de13-64b3-4057-b91c-4b5126962341	Product name	1	20220516
089e0644-1ea8-8654-4113-39f960dd57d5	Product name	3	20210115
1629e00f-54fb-4a43-8306-b58442b23902	Product name	9	20200430
5331c9c8-f64b-11e6-ccf1-071c477fcb0b	Product name	7	20190612
d4880ace-a516-8c47-8dfd-73a4ba5887d7	Product name	2	20180830
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
9f64e0dc-109c-9660-8e0e-91ec987b3817	Product name	6	20171204
dfa879a3-32de-49f0-a7ba-9b9c3e13002f	Product name	1	20171204
8de20f81-8411-4cf1-a8b2-03404ee56d01	Product name	3	20171109
a5f1a68c-0352-4f34-46a3-9b4eed239ed8	Product name	2	20160819
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
355b2224-0895-7135-83f5-d099a6a82a0a	Product name	1	20140508
55be6b50-8cc0-f0f1-74a1-3416a91193aa	Product name	1	20140508
7a0092d1-1e8c-0d78-4f8d-d95fa15cc3cf	Product name	1	20140508
89b93c13-4be8-69f3-b33b-63e64feffb9b	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
50804-085-17	2020-01-31	C162847	48780-1	9d75b9d0-1a9b-f424-e053-dadaa90a57ce	NASAL Allergy 24 Hour Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50804-085-17	NASAL Allergy 24 Hour	120 in 1 BOTTLE, SPRAY	SPRAY, METERED	120		2
50804-085-17	NASAL Allergy 24 Hour	1 in 1 CARTON	SPRAY, METERED	1		2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50804-085	NASAL ALLERGY 24 HOUR (TRIAMCINOLONE ACETONIDE) SPRAY, METERED [GEISS, DESTIN & DUNN INC.]	2	Legacy NDC, 2 package rows	20150619_4b064f5e-b0a2-488c-823d-0ae05154e703.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50804-085-17	ML - Milliliter	50804-085	dcce9cef-0f13-490f-803d-ae020e4a0e11	1	2015-11-12

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
TRIAMCINOLONE ACETONIDE	ACTIVE INGREDIENT	F446C597KA	2
TRIAMCINOLONE ACETONIDE	ACTIVE MOIETY	F446C597KA	2
ANHYDROUS DEXTROSE	INACTIVE INGREDIENT	5SL0G7R0OK	2
BENZALKONIUM CHLORIDE	INACTIVE INGREDIENT	F5UM2KM3W7	2
CARBOXYMETHYLCELLULOSE SODIUM	INACTIVE INGREDIENT	K679OBS311	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	2
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	2
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	2
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	2
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NASAL Allergy 24 Hour
Triamcinolone Acetonide
BENZALKONIUM CHLORIDE
CARBOXYMETHYLCELLULOSE SODIUM
ANHYDROUS DEXTROSE
EDETATE DISODIUM
HYDROCHLORIC ACID
SODIUM HYDROXIDE
CELLULOSE, MICROCRYSTALLINE
POLYSORBATE 80
WATER

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
50804-085	50804-085-17

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
TRIAMCINOLONE ACETONIDE	F446C597KA	ACTIB
BENZALKONIUM CHLORIDE	F5UM2KM3W7	IACT
CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	IACT
ANHYDROUS DEXTROSE	5SL0G7R0OK	IACT
EDETATE DISODIUM	7FLD91C86K	IACT
HYDROCHLORIC ACID	QTT17582CB	IACT
SODIUM HYDROXIDE	55X04QC32I	IACT
CELLULOSE, MICROCRYSTALLINE	OP1R32D61U	IACT
POLYSORBATE 80	6OZP39ZG8H	IACT
WATER	059QF0KO0R	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 10 · 587 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	POWDER, FOR SUSPENSION / ORAL		4441 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTION, SOLUTION / INTRACARDIAC	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	AEROSOL, FOAM / TOPICAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SUSPENSION, EXTENDED RELEASE / INTRALESIONAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
ANHYDROUS DEXTROSE	ANHYDROUS DEXTROSE	5SL0G7R0OK	TABLET, EXTENDED RELEASE / ORAL		30 mg	Exact identifier — unii candidate 14 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	SOLUTION / INTRA-ARTERIAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	TABLET / BUCCAL	4 mg		Exact identifier — unii candidate 44 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	SPRAY, METERED / NASAL		4 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	DROPS / OPHTHALMIC	NA		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRAMUSCULAR	176 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	SUSPENSION / AURICULAR (OTIC)	1 %w/v		Exact identifier — unii candidate 78 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	TABLET, FILM COATED / ORAL	24 mg		Exact identifier — unii candidate 78 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	CONCENTRATE / INTRAVENOUS		4680 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRATHECAL	176 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / INTRAMUSCULAR	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / SOFT TISSUE	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, CHEWABLE, EXTENDED RELEASE / ORAL		144 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTION, POWDER, FOR SOLUTION / INTRATUMOR	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	SUSPENSION/ DROPS / ORAL		4 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTION / INTRASPINAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	CAPSULE / ORAL	160 mg		Exact identifier — unii candidate 44 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRA-AMNIOTIC	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	INJECTION, SOLUTION / INTRAVENOUS		7 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / PARENTERAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, FOR SOLUTION / INTRATHECAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	SUSPENSION, EXTENDED RELEASE / ORAL		40 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	CONCENTRATE / ORAL		20 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	SUSPENSION / OPHTHALMIC	0.06 %w/v		Exact identifier — unii candidate 77 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	INJECTION / INTRASYNOVIAL	0.1 %w/v		Exact identifier — unii candidate 44 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SUSPENSION / INTRASYNOVIAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	GRANULE / ORAL	NA		Exact identifier — unii candidate 44 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTION / PARENTERAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / AURICULAR (OTIC)	0.8 %w/w		Exact identifier — unii candidate 174 equally ranked IID candidates
ANHYDROUS DEXTROSE	ANHYDROUS DEXTROSE	5SL0G7R0OK	INJECTION / SUBCUTANEOUS	7.5 %w/v		Exact identifier — unii candidate 14 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	TABLET, DELAYED RELEASE / ORAL		4 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	INJECTION / INTRA-ARTICULAR		25 mg	Exact identifier — unii candidate 44 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	AEROSOL, FOAM / TOPICAL	0.98 %w/w		Exact identifier — unii candidate 78 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	SOLUTION / AURICULAR (OTIC)	0.1 %w/v		Exact identifier — unii candidate 77 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	SOLUTION / DENTAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	CAPSULE, LIQUID FILLED / ORAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SYRUP / ORAL	71 mg/5ml		Exact identifier — unii candidate 174 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTION, SOLUTION / EPIDURAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	INJECTION / INTRAMUSCULAR	10 %w/v		Exact identifier — unii candidate 77 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTION / INTRA-ARTICULAR	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SUSPENSION / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	SUSPENSION / AURICULAR (OTIC)	0.01 %w/v		Exact identifier — unii candidate 24 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTION / SUBCUTANEOUS	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	LOTION / TOPICAL	0.1 %w/w		Exact identifier — unii candidate 24 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	SOLUTION/ DROPS / OPHTHALMIC	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	SOLUTION/ DROPS / OPHTHALMIC		1 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
ANHYDROUS DEXTROSE	ANHYDROUS DEXTROSE	5SL0G7R0OK	SPRAY / NASAL		36 mg	Exact identifier — unii candidate 14 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	SOLUTION/ DROPS / TOPICAL	0.01 %w/v		Exact identifier — unii candidate 24 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, FILM COATED / ORAL		992 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SOLUTION/ DROPS / TOPICAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	INJECTION, SUSPENSION / INTRAVENOUS	0.5 %w/v		Exact identifier — unii candidate 78 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	SOLUTION / RECTAL		97 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS	78.36 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
HYDROCHLORIC ACID	HYDROCHLORIC ACID	QTT17582CB	INJECTION / INTRATHECAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A078104-001	TRIAMCINOLONE ACETONIDE	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL			2009-07-30
A078104-002	TRIAMCINOLONE ACETONIDE	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL			2014-11-14

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 88 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	A078104-001	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2009-07-30	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A078104-002	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2014-11-14	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A078104-001	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2009-07-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A078104-002	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2014-11-14	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A078104-001	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2009-07-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A078104-002	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2014-11-14	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A078104-001	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2009-07-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A078104-002	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2014-11-14	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078104-001	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2009-07-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078104-002	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2014-11-14	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A078104-001	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2009-07-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A078104-002	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2014-11-14	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078104-001	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2009-07-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078104-002	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2014-11-14	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078104-001	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2009-07-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078104-002	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2014-11-14	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078104-001	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2009-07-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078104-002	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2014-11-14	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A078104-001	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2009-07-30	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A078104-002	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2014-11-14	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A078104-001	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2009-07-30	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A078104-002	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2014-11-14	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A078104-001	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2009-07-30	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A078104-002	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2014-11-14	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A078104-001	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2009-07-30	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A078104-002	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2014-11-14	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A078104-001	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2009-07-30	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A078104-002	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2014-11-14	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A078104-001	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2009-07-30	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A078104-002	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2014-11-14	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A078104-001	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2009-07-30	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A078104-002	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2014-11-14	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A078104-001	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2009-07-30	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A078104-002	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2014-11-14	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A078104-001	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2009-07-30	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A078104-002	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2014-11-14	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A078104-001	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2009-07-30	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A078104-002	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2014-11-14	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A078104-001	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2009-07-30	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A078104-002	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL	2014-11-14	`4b0b4de00fa7…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
e864260c-1438-4ff0-9d20-15ac23097f22			4b064f5e-b0a2-488c-823d-0ae05154e703	2026-08-13	Warnings	Exact identifier spl set id: 4b064f5e-b0a2-488c-823d-0ae05154e703

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.